Current Edition


Sanofi, GSK say COVID vaccine works as booster, but delay key study results

Sanofi and GSK expected to have definitive results for their long-delayed coronavirus vaccine by now, having redesigned their shot after an initial formulation disappointed late …

Continue Reading →

Pfizer again asks FDA to authorize COVID-19 boosters for all adults

Agency advisers had opposed a broad booster dose clearance in September, leading the FDA to limit use to older adults and those at high risk …

Continue Reading →
coronavirus vaccine

J&J foresees end to not-for-profit sales of coronavirus vaccine

J&J has recorded far fewer sales of its coronavirus vaccine than competitors Pfizer and Moderna, partly due to its not-for-profit pricing but also to a …

Continue Reading →
aged 18-60

CureVac scraps its first COVID-19 vaccine and pivots to a second

After months sticking with its coronavirus vaccine, CureVac has finally given up. CureVac executives had long argued the shot could still play a role in …

Continue Reading →
Centers of Disease Control and Prevention

J&J asks FDA to clear booster dose of its coronavirus vaccine

For the past several months, one of the many questions hanging over the booster debate has ben what do with people who got J&J’s shot. …

Continue Reading →
coronavirus vaccine

CureVac scales back mRNA manufacturing for coronavirus vaccine

While not acknowledged directly, the “corresponding changes in demand” could also stem from disappointing clinical trial results CureVac released for its vaccine in mid-June, which …

Continue Reading →

FDA grants full approval to Pfizer, BioNTech’s coronavirus vaccine

The Food and Drug Administration on Monday granted full approval to Pfizer and BioNTech’s coronavirus vaccine, a long-awaited decision that government officials hope could help …

Continue Reading →